FDA NDC Directory · JSON-LD · Markdown

CLORAZEPATE DIPOTASSIUM

NDC 13107-321 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAurolife Pharma LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA071858
Dosage form / routeTABLET · ORAL
Active ingredientsCLORAZEPATE DIPOTASSIUM (15 mg/1)
Marketing started19870717
Marketing ended20270228
Package count1

External sources

Source: openFDA. Public-domain (CC0).